par Lebrun, Philippe 
;Cognard, E;Gontard, P;Bellon-Paul, R;Filloux, C;Berthault, M F;Magnan, C;Ruberte, J;Luppo, M;Pujol, A;Pachera, Nathalie ;Herchuelz, André ;Bosch, F;Van Obbergen, Emmanuel
Référence Diabetologia, 53, 9, page (1935-1946)
Publication Publié, 2010-09
;Cognard, E;Gontard, P;Bellon-Paul, R;Filloux, C;Berthault, M F;Magnan, C;Ruberte, J;Luppo, M;Pujol, A;Pachera, Nathalie ;Herchuelz, André ;Bosch, F;Van Obbergen, Emmanuel Référence Diabetologia, 53, 9, page (1935-1946)
Publication Publié, 2010-09
Article révisé par les pairs
| Résumé : | Suppressor of cytokine signalling (SOCS) proteins are powerful inhibitors of pathways involved in survival and function of pancreatic beta cells. Whereas SOCS1 and SOCS3 have been involved in immune and inflammatory processes, respectively, in beta cells, nothing is known about SOCS2 implication in the pancreas. |
